Search
for
Sort by
Research 751–780 of 777
- Alopecia universalis successfully treated with tofacitinib
- 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- The Sebaceous Gland - Friend or Foe?
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
- Baricitinib Induced Hypoglycemic Seizures in a Patient with Hair Loss and Type I Diabetes Mellitus: A Case Report
- Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Tofacitinib citrate alleviates alopecia universalis symptoms in recent case study
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib
- Treatment of Lichen Planopilaris With Abrocitinib
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Modern dermatology brings treatment even for alopecia areata
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Effects of biomaterials derived from germinated hemp seeds for stressed hair stem cells and immune cells
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- 689 Cell-type-specific nascent transcriptomics through PRECISE-seq reveal molecular principles of tissue dynamics
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review